Compare Manulife Financial Corporation (MFC) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manulife Financial Corporation vs 22nd Century Group Inc — how do they compare? Manulife Financial Corporation trades at $42.5 (market cap $69.48B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Manulife Financial Corporation is far larger — about 111763.5× 22nd Century Group Inc's market cap, and Manulife Financial Corporation pays a 3.23% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Manulife Financial Corporation for 119 Days and 22nd Century Group Inc for 32 Days on average.
| MFC | XXII | |
|---|---|---|
Market Cap | $69.48B | $621.67K |
Volume | 1,347,508 | 45,625 |
Sector | Financials | Consumer Staples |
52-Week High | $44.77 | $483.00 |
52-Week Low | $31.64 | $0.80 |
Typical Hold Time | 119 Days | 32 Days |
Enterprise Value | $64.75B | -$3.69M |
Dividend Yield | 3.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MFC trades at $42.43, up 1.82% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 earnings of $0.79 per share, beating expectations by 1.3%, with revenue growth accelerating to $53.01 billion in 2025. Analyst consensus remains bullish with 57% buy ratings, though the current price exceeds the $34.24 consensus target. Recent institutional activity includes Bank of America's $145 million investment in Q2 2026.
MFC demonstrates solid fundamental growth with improving cash flow trends and expanding revenue, though valuation appears stretched relative to analyst targets. Key risks include premium valuation concerns and competitive pressures in financial services. The stock offers exposure to Asia-driven insurance growth but faces headwinds from technical bearish signals and elevated P/E ratio of 16.22.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
